The risk of ovarian cancer after treatment for infertility

Current Opinion in Obstetrics and Gynecology

Volumn 8, Issue 1, 1996, Pages 32-37

  Bristow, Robert E ^a   Karlan, Beth Y ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; FERTILITY PROMOTING AGENT; HUMAN MENOPAUSAL GONADOTROPIN;

CANCER RISK; DISEASE ASSOCIATION; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HIGH RISK PATIENT; HUMAN; OVARY CANCER; PARITY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR;

EID: 0029880296     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001703-199602000-00008     Document Type: Review

References (35)

1. Heintz APM, Hacker NF, Lagasse LD: Epidemiology and etiology of ovarian cancer: a review. Obstet Gynecol 1985, 66:127-135.
2. Brinton LA, Hoover RN: Epidemiology of Gynecologic Cancers. In Principle and Practice of Gynecologic Oncology. Edited by Hoskins WJ, Perez CA, Young RC. Philadelphia, PA: JB Lippincott Company; 1992:9-12.
3. Hankinson SE, Golditz GA, Hunter DJ, Spencer TL, Rosner B, Stampfer MJ: A quantitative assessment of oral contraceptive use and risk of ovarian cancer. Obstet Gynecol 1992, 80:708-714.
4. Casagrande JT, Pike ML, Ross RK, Louis EW, Roy S, Henderson BE: Incessant ovulation and ovarian cancer. Lancet 1979, ii:170-172.
5. Joly DJ, Lilienfeld AM, Diamond EL, Bross IDJ: An epidemiologic study of the relationship of reproductive experience to cancer of the ovary. Am J Epidemiol 1974, 99:190-209.
6. Nasca PC, Greenwald P, Chorost S, Richert R, Caputo T: An epidemiologic case-control study of ovarian cancer and reproductive factors. Am J Epidemiol 1984, 119:705-713.
7. Booth M, Beral V, Smith P: Risk factors for ovarian cancer: a case-control study. Br J Cancer 1989, 60:592-598.
8. Whittemore AS, Wu ML, Paffenbarger RS, Sarles DL, Kampert JB, Grosser S, Jung DL, Ballon S, Hendrickson M, Mohle-Boetani J: Epithelial ovarian cancer and the ability to conceive. Cancer Res 1989, 49:4047-4052.
9. Fathalla MF: Incessant ovulation: a factor in ovarian neoplasia? [Letter] Lancet 1971, ii:163.
10. Zajicek J: Prevention of ovarian cystomas by inhibition of ovulation: a new concept. J Reprod Med 1978, 2:114.
11. Cramer DW, Welch WR: Determinants of ovarian cancer risk II: Inferences regarding pathogenesis. J Natl Cancer Inst 1983, 71:717-721.
12. Bamford PM, Steele SJ: Uterine and ovarian carcinoma in a patient receiving gonadotropin therapy: a case report. Br J Obstet Gynaecol 1982, 89:962-964.
13. Atlas M, Menczer J: Massive hyperstimulation and borderline carcinoma of the ovary. A possible association. Acta Obstet Gynecol Scand 1982, 61:261-263.
14. Ben-Hur H, Dgani R, Lancet M, Katz Z, Nissim F, Fosenman D: Ovarian carcinoma masquerading as ovarian hyperstimulation syndrome. Acta Obstet Gynecol Scand 1986, 65:813-814.
15. Carter ME, Joyce DN: Ovarian carcinoma in a patient hyperstimulated by gonadotropin therapy for in-vitro fertilization: a case report. J In Vitro Fertil Embryo Transfer 1987, 4:126-128.
16. Kulkarni R, McGarry JM: Follicular stimulation and ovarian cancer [Letter]. BMJ 1989, 299:740.
17. Dietl J: Ovulation and ovarian cancer [Letter]. Lancet 1991, 338:445.
18. Goldberg GL, Runowicz CD: Ovarian carcinoma of low malignant potential, infertility, and induction of ovulation: is there a link? Amer J Obstet Gynecol 1992, 166:853-854.
19. Lopes P, Julou V, Mensier A, Gamier JM, Laborde O, Sagot P, L'Hermite A, Jean M, Barriere P: Ovarian cancer and medically assisted reproduction [In French]. Contracept Fertil Sex 1992, 20:797-798.
20. Balasch J, Barri PN: Follicular stimulation and ovarian cancer. Hum Reprod 1993, 8:990-996.
21. Karlan BY, Marrs R, Lagasse LD: Advanced-stage ovarian carcinoma presenting during infertility evaluation. Am J Obstet Gynecol 1994, 171:1377-1378.
22. Ron E, Lunenfeld B, Menczer J, Blumstein T, Katz L, Oelsner L, Serr D: Cancer incidence in a cohort of infertile women. Am J Epidemiol 1987, 125:780-790.
23. Whittemore AS, Harris R, Itnyre J and The Collaborative Ovarian Cancer Group: Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Amer J Epidemiol 1992, 136:1184-1203.
24. Whittemore AS, Harris R, Itnyre J, Halpern J and The Collaborative Ovarian Cancer Group: Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. I. Methods. Am J Epidemiol 1992, 136:1175-1183.
25. Harris R, Whittemore AS, Itnyre J and The Collaborative Ovarian Cancer Group: Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 US case-control studies. III. Epithelial tumors of low malignant potential in white women. Am J Epidemiol 1992, 136:1204-1211.
26. Cohen J, Forman R, Harlap S, Johannisson E, Lunenfeld B, deMouzon J, Pepperell R, Tarlatzis B, Templeton A: IFFS expert group report on the Whittemore study related to the risk of ovarian cancer associated with use of fertility agents. Hum Reprod 1993, 8:996-999.
27. Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG: Ovarian tumors in a cohort of infertile women. N Engl J Med 1994, 331:771-776. Methodologically sound case-cohort study suggesting an association between ovulation induction and ovarian cancer. Though these data demonstrate inconsistencies with respect to dose-dependency and parity effects, this study is requisite reading for those treating patients for infertility.
28. Harlow BL, Weiss NS, Roth GJ, Chu J, Daling JR: Case-control study of borderline tumors: reproductive history and exposure to exogenous female hormones. Cancer Res 1988, 48:5489-5852.
29. Franceschi S, LaVacachia C, Negri E, Guarner S, Montella M, Conti E, Parazzin F: Fertility drugs and risk of epithelial ovarian cancer in Italy. Hum Reprod 1994, 9:1673-1675.
30. Bandera CA, Cramer DA, Friedman AJ, Sheets EE: Fertility therapy in the setting of a history of invasive epithelial ovarian cancer. Gynecol Oncol 1995, 58:116-118.
31. Graves PE, Surwit EA, Davis JR, Stouffer RL: Adenylate cyclase in human ovarian cancers: sensitivity to gonadotropins and non-hormonal activators. Am J Obstet Gynecol 1985, 153:877-882.
32. Nakano R, Kitamaya S, Yamamoto M, Shirma K, Ooshima A: Localization of gonadotropin binding sites in human neoplasms. Am J Obstet Gynecol 1989, 161:905-910.
33. Shoham Z: Epidemiology, etiology, and fertility drugs in ovarian epithelial carcinoma: where are we today? Fertil Steril 1994, 62:433-448. An excellent review paper detailing the epidemiology and etiology of the development of epithelial ovarian carcinoma. Particular attention is devoted to infertility as an independent risk factor and the various proposed pathologic mechanisms.
34. Risch HA, Marrett LD, Hove GR: Parity, contraception, infertility, and the risk of epithelial ovarian cancer. Am J Epidemiol 1994, 140:585-597. Large case-control study concluding that infertility has little effect on the risk of developing ovarian cancer after separating voluntary from involuntary infertility.
35. Whittemore AS: The risk of ovarian cancer after treatment for infertility [Editorial]. N Engl J Med 1994, 331:805-806.